<DOC>
	<DOCNO>NCT01615822</DOCNO>
	<brief_summary>OZ439 novel , synthetic trioxolane medicine relate artemisinin , advantage long elimination half-life develop administer together potential partner drug e.g . mefloquine single dose cure uncomplicated malaria . The study finding use inform dose design future study . The aim study establish safety , tolerability pharmacokinetics co-administered OZ439 MQ range dose maximum tolerated dose , healthy volunteer .</brief_summary>
	<brief_title>Safety , Tolerability &amp; Pharmacokinetics ( PK ) Co-administered Single Doses OZ439 Mefloquine ( MQ ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Healthy male nonchildbearing potential female volunteer 18 55 year age Female volunteer must negative serum pregnancy test screening Females must nonchildbearing potential Male volunteer partner ( ) must agree use double barrier method contraception least 14 day prior first dose study drug 90 day last dose . Body mass Index 18 30kg/m2 , inclusive ; total body weight &gt; 50 kg Laboratory test screen within normal range clinically significant judged Investigator . Received investigational drug participate another research study within 30 day first dose study drug time study Evidence current history clinically significant oncologic , pulmonary , hepatic , cardiovascular , gastrointestinal , haematologic , metabolic , neurological , immunologic , nephrologic , endocrine , psychiatric disease , clinically significant current infection . Any condition could possibly affect drug absorption , gastrectomy , diarrhea lactose intolerance Use medication , vitamin , herbal supplement , dietary supplement vaccination within 14 day first dose study drug time study , unless prior approval grant . This include drug substrate , inhibitor inducer CYP3A4 . Intermittent use acetaminophen dose 2g/day permitted History drug alcohol abuse within 2 year Screening History alcohol consumption within 24 hour study visit Tobacco user Consumption fruit juice within 7 day prior dose Participation unaccustomed strenuous exercise within 7 day prior Positive urine drug screen Positive test HIV1 , HBsAg HCV Known hypersensitivity MQ artemisinins QTcF great 450msec</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Malaria</keyword>
	<keyword>PK</keyword>
	<keyword>OZ439</keyword>
	<keyword>Mefloquine</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>